Literature DB >> 8646272

The Mania Rating Scale (MRS): further reliability and validity studies with children.

M A Fristad1, R A Weller, E B Weller.   

Abstract

Empirical studies of prepubertal mania are scarce and are limited by a lack of assessment instruments. This study extended previous research on the Mania Rating Scale (MRS) in children. Psychometric properties of the MRS were examined in three new groups of prepubertal subjects: (1) 10 inpatients with bipolar disorder, (2) 10 inpatients with attention deficit hyperactivity disorder (ADHD), and (3) 10 outpatients with ADHD. Subjects were administered the MRS and other standard depression and hyperactivity measures. The MRS had adequate internal consistency (alpha = .80), convergent validity (r = .83, p < .0001), and divergent validity (no significant correlations with depression and hyperactivity ratings). Items assessing "classic" manic symptoms (e.g., elevated mood, increased sexual interest, pressured speech, racing thoughts) effectively discriminated the bipolar group from both comparison groups, while items assessing increased activity level and irritability did not. Results suggest that the MRS can be used with children.

Entities:  

Mesh:

Year:  1995        PMID: 8646272     DOI: 10.3109/10401239509149039

Source DB:  PubMed          Journal:  Ann Clin Psychiatry        ISSN: 1040-1237            Impact factor:   1.567


  33 in total

1.  Validity of the Expressed Emotion Adjective Checklist (EEAC) in Caregivers of Children with Mood Disorders.

Authors:  Nicole M Klaus; Guillermo Perez Algorta; Andrea S Young; Mary A Fristad
Journal:  Couple Family Psychol       Date:  2015-03

2.  Characteristics of children with elevated symptoms of mania: the Longitudinal Assessment of Manic Symptoms (LAMS) study.

Authors:  Robert L Findling; Eric A Youngstrom; Mary A Fristad; Boris Birmaher; Robert A Kowatch; L Eugene Arnold; Thomas W Frazier; David Axelson; Neal Ryan; Christine A Demeter; Mary Kay Gill; Benjamin Fields; Judith Depew; Shawn M Kennedy; Linda Marsh; Brieana M Rowles; Sarah McCue Horwitz
Journal:  J Clin Psychiatry       Date:  2010-10-05       Impact factor: 4.384

3.  Omega-3 Fatty Acid Plasma Levels Before and After Supplementation: Correlations with Mood and Clinical Outcomes in the Omega-3 and Therapy Studies.

Authors:  L Eugene Arnold; Andrea S Young; Martha A Belury; Rachel M Cole; Barbara Gracious; Adina M Seidenfeld; Hannah Wolfson; Mary A Fristad
Journal:  J Child Adolesc Psychopharmacol       Date:  2017-02-03       Impact factor: 2.576

4.  Three-year latent class trajectories of attention-deficit/hyperactivity disorder (ADHD) symptoms in a clinical sample not selected for ADHD.

Authors:  L Eugene Arnold; Stephen J Ganocy; Katherine Mount; Eric A Youngstrom; Thomas Frazier; Mary Fristad; Sarah M Horwitz; Boris Birmaher; Robert Findling; Robert A Kowatch; Christine Demeter; David Axelson; Mary Kay Gill; Linda Marsh
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2014-04-30       Impact factor: 8.829

5.  Anxiety in children with mood disorders: a treatment help or hindrance?

Authors:  Colleen M Cummings; Mary A Fristad
Journal:  J Abnorm Child Psychol       Date:  2012-04

6.  Examination of disruptive behavior outcomes and moderation in a randomized psychotherapy trial for mood disorders.

Authors:  Khrista Boylan; Heather A Macpherson; Mary A Fristad
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2013-07       Impact factor: 8.829

7.  Portability of a screener for pediatric bipolar disorder to a diverse setting.

Authors:  Andrew J Freeman; Eric A Youngstrom; Thomas W Frazier; Jennifer Kogos Youngstrom; Christine Demeter; Robert L Findling
Journal:  Psychol Assess       Date:  2011-09-26

8.  Efficacy, long-term safety, and tolerability of ziprasidone in children and adolescents with bipolar disorder.

Authors:  Robert L Findling; Idil Cavuş; Elizabeth Pappadopulos; Douglas G Vanderburg; Jeffrey H Schwartz; Balarama K Gundapaneni; Melissa P DelBello
Journal:  J Child Adolesc Psychopharmacol       Date:  2013-10-10       Impact factor: 2.576

9.  Abnormal amygdala and prefrontal cortex activation to facial expressions in pediatric bipolar disorder.

Authors:  Amy S Garrett; Allan L Reiss; Meghan E Howe; Ryan G Kelley; Manpreet K Singh; Nancy E Adleman; Asya Karchemskiy; Kiki D Chang
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2012-06-27       Impact factor: 8.829

10.  Clinical significance of treatment effects with aripiprazole versus placebo in a study of manic or mixed episodes associated with pediatric bipolar I disorder.

Authors:  Eric Youngstrom; Joan Zhao; Raymond Mankoski; Robert A Forbes; Ronald M Marcus; William Carson; Robert McQuade; Robert L Findling
Journal:  J Child Adolesc Psychopharmacol       Date:  2013-03-12       Impact factor: 2.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.